{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:04:39Z","timestamp":1792825479345,"version":"4.5.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T00:00:00Z","timestamp":1474502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/nrrheum.2016.147","type":"journal-article","created":{"date-parts":[[2016,9,22]],"date-time":"2016-09-22T02:22:00Z","timestamp":1474510920000},"page":"703-715","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles"],"prefix":"10.1038","volume":"12","author":[{"given":"Fr\u00e9d\u00e9ric","family":"Coutant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Miossec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,22]]},"reference":[{"key":"BFnrrheum2016147_CR1","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMra1402225","volume":"372","author":"MC Dalakas","year":"2015","unstructured":"Dalakas, M. C. Inflammatory muscle diseases. N. Engl. J. Med. 372, 1734\u20131747 (2015).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2016147_CR2","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJM199805073381906","volume":"338","author":"BH Hahn","year":"1998","unstructured":"Hahn, B. H. Antibodies to DNA. N. Engl. J. Med. 338, 1359\u20131368 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnrrheum2016147_CR3","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/JCI60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre, U.  et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122, 1791\u20131802 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR4","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar2276","volume":"9","author":"M Koenig","year":"2007","unstructured":"Koenig, M., Fritzler, M. J., Targoff, I. N., Troyanov, Y. & Sen\u00e9cal, J.-L. Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes. Arthritis Res. Ther. 9, R78 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nrrheum.2015.178","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos, G. C. Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells. Nat. Rev. Rheumatol. 12, 74\u201376 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2016147_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrrheum.2016.74","volume":"12","author":"A Petrelli","year":"2016","unstructured":"Petrelli, A. & van Wijk, F. CD8+ T cells in human autoimmune arthritis: the unusual suspects. Nat. Rev. Rheumatol. 12, 421\u2013428 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2016147_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/ar4116","volume":"14","author":"V Malmstr\u00f6m","year":"2012","unstructured":"Malmstr\u00f6m, V., Venalis, P. & Albrecht, I. T cells in myositis. Arthritis Res. Ther. 14, 230 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR8","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.coi.2006.09.014","volume":"18","author":"V Pascual","year":"2006","unstructured":"Pascual, V., Farkas, L. & Banchereau, J. Systemic lupus erythematosus: all roads lead to type I interferons. Curr. Opin. Immunol. 18, 676\u2013682 (2006).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnrrheum2016147_CR9","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","volume":"11","author":"P Miossec","year":"2012","unstructured":"Miossec, P. & Kolls, J. K. Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763\u2013776 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnrrheum2016147_CR10","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1172\/JCI118749","volume":"97","author":"N Goebels","year":"1996","unstructured":"Goebels, N.  et al. Differential expression of perforin in muscle-infiltrating T cells in polymyositis and dermatomyositis. J. Clin. Invest. 97, 2905\u20132910 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR11","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.4161\/15384101.2014.946377","volume":"13","author":"CE Zielinski","year":"2014","unstructured":"Zielinski, C. E. Autoimmunity beyond TH17: GM-CSF producing T cells. Cell Cycle 13, 2489\u20132490 (2014).","journal-title":"Cell Cycle"},{"key":"BFnrrheum2016147_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri3477","volume":"13","author":"D Ganguly","year":"2013","unstructured":"Ganguly, D., Haak, S., Sisirak, V. & Reizis, B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 13, 566\u2013577 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nri3712","volume":"14","author":"M Guilliams","year":"2014","unstructured":"Guilliams, M.  et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571\u2013578 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR14","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","volume":"284","author":"FP Siegal","year":"1999","unstructured":"Siegal, F. P.  et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835\u20131837 (1999).","journal-title":"Science"},{"key":"BFnrrheum2016147_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.immuni.2007.01.017","volume":"26","author":"B Le\u00f3n","year":"2007","unstructured":"Le\u00f3n, B., L\u00f3pez-Bravo, M. & Ardav\u00edn, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519\u2013531 (2007).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR16","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1084\/jem.20101563","volume":"207","author":"H Hammad","year":"2010","unstructured":"Hammad, H.  et al. Inflammatory dendritic cells\u2014not basophils\u2014are necessary and sufficient for induction of TH2 immunity to inhaled house dust mite allergen. J. Exp. Med. 207, 2097\u20132111 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR17","first-page":"5468","volume":"186","author":"IK Campbell","year":"2011","unstructured":"Campbell, I. K.  et al. Differentiation of inflammatory dendritic cells is mediated by NF-\u03baB1-dependent GM-CSF production in CD4 T cells. J. Immunol. Baltim. Md. 186, 5468\u20135477 (2011).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.immuni.2012.10.018","volume":"38","author":"E Segura","year":"2013","unstructured":"Segura, E.  et al. Human inflammatory dendritic cells induce TH17 cell differentiation. Immunity 38, 336\u2013348 (2013).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/S0198-8859(99)00030-0","volume":"60","author":"RM Steinman","year":"1999","unstructured":"Steinman, R. M., Inaba, K., Turley, S., Pierre, P. & Mellman, I. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60, 562\u2013567 (1999).","journal-title":"Hum. Immunol."},{"key":"BFnrrheum2016147_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1083\/jcb.200110066","volume":"155","author":"S Somersan","year":"2001","unstructured":"Somersan, S. & Bhardwaj, N. Tethering and tickling: a new role for the phosphatidylserine receptor. J. Cell Biol. 155, 501\u2013504 (2001).","journal-title":"J. Cell Biol."},{"key":"BFnrrheum2016147_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","volume":"987","author":"RM Steinman","year":"2003","unstructured":"Steinman, R. M.  et al. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. NY Acad. Sci. 987, 15\u201325 (2003).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2016147_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway","year":"2002","unstructured":"Janeway, C. A. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol. 20, 197\u2013216 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnrrheum2016147_CR23","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/15200","volume":"5","author":"S Gallucci","year":"1999","unstructured":"Gallucci, S., Lolkema, M. & Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5, 1249\u20131255 (1999).","journal-title":"Nat. Med."},{"key":"BFnrrheum2016147_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2013.00138","volume":"4","author":"PM Gallo","year":"2013","unstructured":"Gallo, P. M. & Gallucci, S. The dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunity. Front. Immunol. 4, 138 (2013).","journal-title":"Front. Immunol."},{"key":"BFnrrheum2016147_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.it.2013.07.006","volume":"34","author":"KP Walsh","year":"2013","unstructured":"Walsh, K. P. & Mills, K. H. Dendritic cells and other innate determinants of T helper cell polarisation. Trends Immunol. 34, 521\u2013530 (2013).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2016147_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1084\/jem.20111457","volume":"209","author":"E Segura","year":"2012","unstructured":"Segura, E.  et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J. Exp. Med. 209, 653\u2013660 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR27","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.immuni.2013.04.011","volume":"38","author":"A Schlitzer","year":"2013","unstructured":"Schlitzer, A.  et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970\u2013983 (2013).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR28","first-page":"4335","volume":"193","author":"CI Yu","year":"2014","unstructured":"Yu, C. I.  et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J. Immunol. Baltim. Md. 1950193, 4335\u20134343 (2014).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR29","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.immuni.2008.09.002","volume":"29","author":"JA Villadangos","year":"2008","unstructured":"Villadangos, J. A. & Young, L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 29, 352\u2013361 (2008).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR30","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nri3027","volume":"11","author":"B Reizis","year":"2011","unstructured":"Reizis, B., Colonna, M., Trinchieri, G., Barrat, F. & Gilliet, M. Plasmacytoid dendritic cells: one-trick ponies or workhorses of the immune system? Nat. Rev. Immunol. 11, 558\u2013565 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nri3865","volume":"15","author":"M Swiecki","year":"2015","unstructured":"Swiecki, M. & Colonna, M. The multifaceted biology of plasmacytoid dendritic cells. Nat. Rev. Immunol. 15, 471\u2013485 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR32","first-page":"4433","volume":"173","author":"EA Moseman","year":"2004","unstructured":"Moseman, E. A.  et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J. Immunol. Baltim. Md. 1950173, 4433\u20134442 (2004).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR33","first-page":"2999","volume":"184","author":"S Hanabuchi","year":"2010","unstructured":"Hanabuchi, S.  et al. Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J. Immunol. Baltim. Md. 1950184, 2999\u20133007 (2010).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR34","doi-asserted-by":"publisher","first-page":"5366","DOI":"10.1182\/blood-2009-10-248260","volume":"115","author":"E Mart\u00edn-Gayo","year":"2010","unstructured":"Mart\u00edn-Gayo, E., Sierra-Filardi, E., Corb\u00ed, A. L. & Toribio, M. L. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115, 5366\u20135375 (2010).","journal-title":"Blood"},{"key":"BFnrrheum2016147_CR35","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","volume":"207","author":"SL Jongbloed","year":"2010","unstructured":"Jongbloed, S. L.  et al. Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J. Exp. Med. 207, 1247\u20131260 (2010).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR36","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1182\/blood-2013-04-495424","volume":"122","author":"G Nizzoli","year":"2013","unstructured":"Nizzoli, G.  et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122, 932\u2013942 (2013).","journal-title":"Blood"},{"key":"BFnrrheum2016147_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1189\/jlb.0912452","volume":"93","author":"C H\u00e9mont","year":"2013","unstructured":"H\u00e9mont, C., Neel, A., Heslan, M., Braudeau, C. & Josien, R. Human blood mDC subsets exhibit distinct TLR repertoire and responsiveness. J. Leukoc. Biol. 93, 599\u2013609 (2013).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrrheum2016147_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/icb.2010.28","volume":"88","author":"H Ueno","year":"2010","unstructured":"Ueno, H., Schmitt, N., Palucka, A. K. & Banchereau, J. Dendritic cells and humoral immunity in humans. Immunol. Cell Biol. 88, 376\u2013380 (2010).","journal-title":"Immunol. Cell Biol."},{"key":"BFnrrheum2016147_CR39","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000082101","volume":"8","author":"G Jego","year":"2005","unstructured":"Jego, G., Pascual, V., Palucka, A. K. & Banchereau, J. Dendritic cells control B cell growth and differentiation. Curr. Dir. Autoimmun. 8, 124\u2013139 (2005).","journal-title":"Curr. Dir. Autoimmun."},{"key":"BFnrrheum2016147_CR40","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1126\/science.1125703","volume":"312","author":"H Qi","year":"2006","unstructured":"Qi, H., Egen, J. G., Huang, A. Y. C. & Germain, R. N. Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science 312, 1672\u20131676 (2006).","journal-title":"Science"},{"key":"BFnrrheum2016147_CR41","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1074-7613(02)00398-9","volume":"17","author":"I MacLennan","year":"2002","unstructured":"MacLennan, I. & Vinuesa, C. Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity 17, 235\u2013238 (2002).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR42","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000082105","volume":"8","author":"SL Kalled","year":"2005","unstructured":"Kalled, S. L., Ambrose, C. & Hsu, Y.-M. The biochemistry and biology of BAFF, APRIL and their receptors. Curr. Dir. Autoimmun. 8, 206\u2013242 (2005).","journal-title":"Curr. Dir. Autoimmun."},{"key":"BFnrrheum2016147_CR43","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/S0198-8859(02)00756-5","volume":"63","author":"MA Gill","year":"2002","unstructured":"Gill, M. A.  et al. Blood dendritic cells and DC-poietins in systemic lupus erythematosus. Hum. Immunol. 63, 1172\u20131180 (2002).","journal-title":"Hum. Immunol."},{"key":"BFnrrheum2016147_CR44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/0961203308089410","volume":"17","author":"O Jin","year":"2008","unstructured":"Jin, O.  et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 17, 654\u2013662 (2008).","journal-title":"Lupus"},{"key":"BFnrrheum2016147_CR45","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1006\/jaut.1998.0215","volume":"11","author":"B Cederblad","year":"1998","unstructured":"Cederblad, B.  et al. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J. Autoimmun. 11, 465\u2013470 (1998).","journal-title":"J. Autoimmun."},{"key":"BFnrrheum2016147_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","volume":"159","author":"L Farkas","year":"2001","unstructured":"Farkas, L., Beiske, K., Lund-Johansen, F., Brandtzaeg, P. & Jahnsen, F. L. Plasmacytoid dendritic cells (natural interferon-\u03b1\/\u03b2-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am. J. Pathol. 159, 237\u2013243 (2001).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2016147_CR47","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2249.2005.02897.x","volume":"142","author":"K Migita","year":"2005","unstructured":"Migita, K.  et al. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin. Exp. Immunol. 142, 84\u201391 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2016147_CR48","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/ar1864","volume":"8","author":"SL Jongbloed","year":"2006","unstructured":"Jongbloed, S. L.  et al. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther. 8, R15 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/path.1607","volume":"204","author":"G Page","year":"2004","unstructured":"Page, G. & Miossec, P. Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression. J. Pathol. 204, 28\u201338 (2004).","journal-title":"J. Pathol."},{"key":"BFnrrheum2016147_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nri1845","volume":"6","author":"C Reis e Sousa","year":"2006","unstructured":"Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476\u2013483 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR51","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.it.2010.05.004","volume":"31","author":"S Sozzani","year":"2010","unstructured":"Sozzani, S., Vermi, W., Del Prete, A. & Facchetti, F. Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 31, 270\u2013277 (2010).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2016147_CR52","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1191\/096120301678416042","volume":"10","author":"S Blomberg","year":"2001","unstructured":"Blomberg, S.  et al. Presence of cutaneous interferon-\u03b1 producing cells in patients with systemic lupus erythematosus. Lupus 10, 484\u2013490 (2001).","journal-title":"Lupus"},{"key":"BFnrrheum2016147_CR53","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.molimm.2007.04.029","volume":"45","author":"N Fiore","year":"2008","unstructured":"Fiore, N.  et al. Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. Mol. Immunol. 45, 259\u2013265 (2008).","journal-title":"Mol. Immunol."},{"key":"BFnrrheum2016147_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/art.23186","volume":"58","author":"M Tucci","year":"2008","unstructured":"Tucci, M.  et al. Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis: role of interleukin-18. Arthritis Rheum. 58, 251\u2013262 (2008).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR55","doi-asserted-by":"publisher","first-page":"940","DOI":"10.2353\/ajpath.2008.070703","volume":"172","author":"MC Lebre","year":"2008","unstructured":"Lebre, M. C.  et al. Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles. Am. J. Pathol. 172, 940\u2013950 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2016147_CR56","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1002\/art.22558","volume":"56","author":"CM L\u00f3pez de Padilla","year":"2007","unstructured":"L\u00f3pez de Padilla, C. M.  et al. Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis. Arthritis Rheum. 56, 1658\u20131668 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR57","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/11360","volume":"5","author":"M Cella","year":"1999","unstructured":"Cella, M.  et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5, 919\u2013923 (1999).","journal-title":"Nat. Med."},{"key":"BFnrrheum2016147_CR58","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1084\/jem.20041310","volume":"201","author":"W Vermi","year":"2005","unstructured":"Vermi, W.  et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509\u2013515 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbrc.2009.01.071","volume":"380","author":"J Skrzeczy\u0144ska-Moncznik","year":"2009","unstructured":"Skrzeczy\u0144ska-Moncznik, J.  et al. Potential role of chemerin in recruitment of plasmacytoid dendritic cells to diseased skin. Biochem. Biophys. Res. Commun. 380, 323\u2013327 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrrheum2016147_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1084\/jem.20080129","volume":"206","author":"C Albanesi","year":"2009","unstructured":"Albanesi, C.  et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J. Exp. Med. 206, 249\u2013258 (2009).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR61","doi-asserted-by":"publisher","first-page":"R158","DOI":"10.1186\/ar3475","volume":"13","author":"K Kaneko","year":"2011","unstructured":"Kaneko, K.  et al. Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis. Arthritis Res. Ther. 13, R158 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR62","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.yexmp.2011.10.006","volume":"92","author":"K Eisinger","year":"2012","unstructured":"Eisinger, K.  et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp. Mol. Pathol. 92, 90\u201396 (2012).","journal-title":"Exp. Mol. Pathol."},{"key":"BFnrrheum2016147_CR63","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.cytogfr.2011.11.004","volume":"22","author":"B Bondue","year":"2011","unstructured":"Bondue, B., Wittamer, V. & Parmentier, M. Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine Growth Factor Rev. 22, 331\u2013338 (2011).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnrrheum2016147_CR64","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1002\/art.22860","volume":"56","author":"M-L Eloranta","year":"2007","unstructured":"Eloranta, M.-L.  et al. A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52\/anti-Ro 60 autoantibodies. Arthritis Rheum. 56, 3112\u20133124 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR65","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/art.11428","volume":"50","author":"G Page","year":"2004","unstructured":"Page, G., Chevrel, G. & Miossec, P. Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum. 50, 199\u2013208 (2004).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR66","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1084\/jem.20021215","volume":"196","author":"K Liu","year":"2002","unstructured":"Liu, K.  et al. Immune tolerance after delivery of dying cells to dendritic cells in situ. J. Exp. Med. 196, 1091\u20131097 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR67","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1182\/blood-2002-06-1769","volume":"101","author":"AE Morelli","year":"2003","unstructured":"Morelli, A. E.  et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101, 611\u2013620 (2003).","journal-title":"Blood"},{"key":"BFnrrheum2016147_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2545","volume":"9","author":"DR Green","year":"2009","unstructured":"Green, D. R., Ferguson, T., Zitvogel, L. & Kroemer, G. Immunogenic and tolerogenic cell death. Nat. Rev. Immunol. 9, 353\u2013363 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1084\/jem.20012094","volume":"196","author":"PL Cohen","year":"2002","unstructured":"Cohen, P. L.  et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196, 135\u2013140 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR70","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","volume":"73","author":"J Leffler","year":"2014","unstructured":"Leffler, J., Bengtsson, A. A. & Blom, A. M. The complement system in systemic lupus erythematosus: an update. Ann. Rheum. Dis. 73, 1601\u20131606 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016147_CR71","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/0961203309103027","volume":"18","author":"CY Hu","year":"2009","unstructured":"Hu, C. Y.  et al. Genetic polymorphism in milk fat globule-EGF factor 8 (MFG-E8) is associated with systemic lupus erythematosus in human. Lupus 18, 676\u2013681 (2009).","journal-title":"Lupus"},{"key":"BFnrrheum2016147_CR72","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1084\/jem.20050914","volume":"202","author":"FJ Barrat","year":"2005","unstructured":"Barrat, F. J.  et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202, 1131\u20131139 (2005).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR73","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/ni.2670","volume":"14","author":"ZG Ramirez-Ortiz","year":"2013","unstructured":"Ramirez-Ortiz, Z. G.  et al. The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity. Nat. Immunol. 14, 917\u2013926 (2013).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016147_CR74","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20040342","volume":"200","author":"K Asano","year":"2004","unstructured":"Asano, K.  et al. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J. Exp. Med. 200, 459\u2013467 (2004).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR75","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1172\/JCI43254","volume":"121","author":"Y Peng","year":"2011","unstructured":"Peng, Y. & Elkon, K. B. Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J. Clin. Invest. 121, 2221\u20132241 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR76","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/00002281-200309000-00006","volume":"15","author":"S White","year":"2003","unstructured":"White, S. & Rosen, A. Apoptosis in systemic lupus erythematosus. Curr. Opin. Rheumatol. 15, 557\u2013562 (2003).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2016147_CR77","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nm1590","volume":"13","author":"R Baccala","year":"2007","unstructured":"Baccala, R., Hoebe, K., Kono, D. H., Beutler, B. & Theofilopoulos, A. N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13, 543\u2013551 (2007).","journal-title":"Nat. Med."},{"key":"BFnrrheum2016147_CR78","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1172\/JCI81059","volume":"125","author":"H Li","year":"2015","unstructured":"Li, H.  et al. Interferon-induced mechanosensing defects impede apoptotic cell clearance in lupus. J. Clin. Invest. 125, 2877\u20132890 (2015).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/art.33350","volume":"64","author":"A Tournadre","year":"2012","unstructured":"Tournadre, A., Lenief, V., Eljaafari, A. & Miossec, P. Immature muscle precursors are a source of interferon-\u03b2 in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation. Arthritis Rheum. 64, 533\u2013541 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR80","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.immuni.2012.03.027","volume":"36","author":"M Greter","year":"2012","unstructured":"Greter, M.  et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity 36, 1031\u20131046 (2012).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR81","doi-asserted-by":"publisher","unstructured":"Reynolds, G.  et al. Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis. Ann. Rheum. Dis. \n                    http:\/\/dx.doi.org\/10.1136\/annrheumdis-2014-206578\n                    \n                   (2015).","DOI":"10.1136\/annrheumdis-2014-206578"},{"key":"BFnrrheum2016147_CR82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/eji.201344184","volume":"44","author":"G Benedetti","year":"2014","unstructured":"Benedetti, G. & Miossec, P. Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis. Eur. J. Immunol. 44, 339\u2013347 (2014).","journal-title":"Eur. J. Immunol."},{"key":"BFnrrheum2016147_CR83","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/ard.2004.032359","volume":"64","author":"G Chevrel","year":"2005","unstructured":"Chevrel, G., Granet, C. & Miossec, P. Contribution of tumour necrosis factor \u03b1 and interleukin (IL) 1\u03b2 to IL6 production, NF-\u03baB nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann. Rheum. Dis. 64, 1257\u20131262 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016147_CR84","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0165-5728(03)00032-8","volume":"137","author":"G Chevrel","year":"2003","unstructured":"Chevrel, G.  et al. Interleukin-17 increases the effects of IL-1\u03b2 on muscle cells: arguments for the role of T cells in the pathogenesis of myositis. J. Neuroimmunol. 137, 125\u2013133 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnrrheum2016147_CR85","first-page":"1262","volume":"29","author":"M Benderdour","year":"2002","unstructured":"Benderdour, M.  et al. Interleukin 17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via AP-1 dependent activation: differential activation of AP-1 members by IL-17 and IL-1beta. J. Rheumatol. 29, 1262\u20131272 (2002).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2016147_CR86","first-page":"2602","volume":"29","author":"S Pacquelet","year":"2002","unstructured":"Pacquelet, S.  et al. Interleukin 17, a nitric oxide-producing cytokine with a peroxynitrite-independent inhibitory effect on proteoglycan synthesis. J. Rheumatol. 29, 2602\u20132610 (2002).","journal-title":"J. Rheumatol."},{"key":"BFnrrheum2016147_CR87","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrrheum.2009.217","volume":"5","author":"H Takayanagi","year":"2009","unstructured":"Takayanagi, H. Osteoimmunology and the effects of the immune system on bone. Nat. Rev. Rheumatol. 5, 667\u2013676 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrrheum2016147_CR88","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/ard.2010.143768","volume":"70","author":"A Hot","year":"2011","unstructured":"Hot, A. & Miossec, P. Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes. Ann. Rheum. Dis. 70, 727\u2013732 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016147_CR89","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar4179","volume":"15","author":"S-Y Lee","year":"2013","unstructured":"Lee, S.-Y.  et al. IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation. Arthritis Res. Ther. 15, R31 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR90","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/art.21211","volume":"52","author":"G Page","year":"2005","unstructured":"Page, G. & Miossec, P. RANK and RANKL expression as markers of dendritic cell-T cell interactions in paired samples of rheumatoid synovium and lymph nodes. Arthritis Rheum. 52, 2307\u20132312 (2005).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR91","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/35046102","volume":"408","author":"H Takayanagi","year":"2000","unstructured":"Takayanagi, H.  et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-\u03b3. Nature 408, 600\u2013605 (2000).","journal-title":"Nature"},{"key":"BFnrrheum2016147_CR92","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2004-01-0041","volume":"104","author":"A Rivollier","year":"2004","unstructured":"Rivollier, A.  et al. Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment. Blood 104, 4029\u20134037 (2004).","journal-title":"Blood"},{"key":"BFnrrheum2016147_CR93","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nri2358","volume":"8","author":"M Gilliet","year":"2008","unstructured":"Gilliet, M., Cao, W. & Liu, Y.-J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8, 594\u2013606 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"BFnrrheum2016147_CR94","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/intimm\/14.4.411","volume":"14","author":"D Braun","year":"2002","unstructured":"Braun, D., Caramalho, I. & Demengeot, J. IFN-\u03b1\/\u03b2 enhances BCR-dependent B cell responses. Int. Immunol. 14, 411\u2013419 (2002).","journal-title":"Int. Immunol."},{"key":"BFnrrheum2016147_CR95","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","volume":"14","author":"A Le Bon","year":"2001","unstructured":"Le Bon, A.  et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14, 461\u2013470 (2001).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR96","first-page":"2074","volume":"176","author":"A Le Bon","year":"2006","unstructured":"Le Bon, A.  et al. Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J. Immunol. Baltim. Md. 1950176, 2074\u20132078 (2006).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1172\/JCI23025","volume":"115","author":"TK Means","year":"2005","unstructured":"Means, T. K.  et al. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115, 407\u2013417 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR98","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo, G. S.  et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnrrheum2016147_CR99","doi-asserted-by":"publisher","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","volume":"3","author":"R Lande","year":"2011","unstructured":"Lande, R.  et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnrrheum2016147_CR100","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur, R.  et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci. Transl. Med. 5, 178ra40 (2013).","journal-title":"Sci. Transl. Med."},{"key":"BFnrrheum2016147_CR101","first-page":"3372","volume":"182","author":"V Lombardi","year":"2009","unstructured":"Lombardi, V., Van Overtvelt, L., Horiot, S. & Moingeon, P. Human dendritic cells stimulated via TLR7 and\/or TLR8 induce the sequential production of Il-10, IFN-\u03b3, and IL-17A by naive CD4+ T cells. J. Immunol. Baltim. Md. 182, 3372\u20133379 (2009).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR102","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1126\/science.1064890","volume":"294","author":"P Blanco","year":"2001","unstructured":"Blanco, P., Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-\u03b1 in systemic lupus erythematosus. Science 294, 1540\u20131543 (2001).","journal-title":"Science"},{"key":"BFnrrheum2016147_CR103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2010.02.017","volume":"50","author":"R Zhang","year":"2010","unstructured":"Zhang, R.  et al. Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine 50, 195\u2013203 (2010).","journal-title":"Cytokine"},{"key":"BFnrrheum2016147_CR104","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/ni829","volume":"3","author":"MB Litinskiy","year":"2002","unstructured":"Litinskiy, M. B.  et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3, 822\u2013829 (2002).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016147_CR105","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1084\/jem.20030448","volume":"198","author":"A MartIn-Fontecha","year":"2003","unstructured":"MartIn-Fontecha, A.  et al. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198, 615\u2013621 (2003).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR106","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.immuni.2004.06.014","volume":"21","author":"L Ohl","year":"2004","unstructured":"Ohl, L.  et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21, 279\u2013288 (2004).","journal-title":"Immunity"},{"key":"BFnrrheum2016147_CR107","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1151869","volume":"319","author":"LM Wakim","year":"2008","unstructured":"Wakim, L. M., Waithman, J., van Rooijen, N., Heath, W. R. & Carbone, F. R. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 319, 198\u2013202 (2008).","journal-title":"Science"},{"key":"BFnrrheum2016147_CR108","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1749-6632.2009.04805.x","volume":"1173","author":"M Tucci","year":"2009","unstructured":"Tucci, M., Ciavarella, S., Strippoli, S., Dammacco, F. & Silvestris, F. Oversecretion of cytokines and chemokines in lupus nephritis is regulated by intraparenchymal dendritic cells: a review. Ann. NY Acad. Sci. 1173, 449\u2013457 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrrheum2016147_CR109","first-page":"5333","volume":"168","author":"G Page","year":"2002","unstructured":"Page, G., Lebecque, S. & Miossec, P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J. Immunol. Baltim. Md. 168, 5333\u20135341 (2002).","journal-title":"J. Immunol. Baltim. Md."},{"key":"BFnrrheum2016147_CR110","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1016\/j.ajpath.2015.03.012","volume":"185","author":"AR Noort","year":"2015","unstructured":"Noort, A. R.  et al. Tertiary lymphoid structures in rheumatoid arthritis: NF-\u03baB-inducing kinase-positive endothelial cells as central players. Am. J. Pathol. 185, 1935\u20131943 (2015).","journal-title":"Am. J. Pathol."},{"key":"BFnrrheum2016147_CR111","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/ard.56.2.140","volume":"56","author":"KE Aziz","year":"1997","unstructured":"Aziz, K. E., McCluskey, P. J. & Wakefield, D. Characterisation of follicular dendritic cells in labial salivary glands of patients with primary Sj\u00f6gren syndrome: comparison with tonsillar lymphoid follicles. Ann. Rheum. Dis. 56, 140\u2013143 (1997).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016147_CR112","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.0105-2896.2009.00861.x","volume":"233","author":"A Manzo","year":"2010","unstructured":"Manzo, A., Bombardieri, M., Humby, F. & Pitzalis, C. Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage\/remodeling. Immunol. Rev. 233, 267\u2013285 (2010).","journal-title":"Immunol. Rev."},{"key":"BFnrrheum2016147_CR113","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0b013e32835fd8eb","volume":"25","author":"C Pitzalis","year":"2013","unstructured":"Pitzalis, C., Kelly, S. & Humby, F. New learnings on the pathophysiology of RA from synovial biopsies. Curr. Opin. Rheumatol. 25, 334\u2013344 (2013).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrrheum2016147_CR114","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.imlet.2012.04.013","volume":"145","author":"E Corsiero","year":"2012","unstructured":"Corsiero, E.  et al. Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases. Immunol. Lett. 145, 62\u201367 (2012).","journal-title":"Immunol. Lett."},{"key":"BFnrrheum2016147_CR115","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ni.2053","volume":"12","author":"J Rangel-Moreno","year":"2011","unstructured":"Rangel-Moreno, J.  et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639\u2013646 (2011).","journal-title":"Nat. Immunol."},{"key":"BFnrrheum2016147_CR116","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1371\/journal.pmed.0060001","volume":"6","author":"F Humby","year":"2009","unstructured":"Humby, F.  et al. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 6, e1 (2009).","journal-title":"PLoS Med."},{"key":"BFnrrheum2016147_CR117","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot, E. J.  et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 43, 1831\u20131835 (2000).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR118","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar4130","volume":"15","author":"R Thomas","year":"2013","unstructured":"Thomas, R. Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis. Arthritis Res. Ther. 15, 204 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"BFnrrheum2016147_CR119","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/978-1-61737-979-6_11","volume":"707","author":"C Daniel","year":"2011","unstructured":"Daniel, C., Ploegh, H. & von Boehmer, H. Antigen-specific induction of regulatory T cells in vivo and in vitro. Methods Mol. Biol. 707, 173\u2013185 (2011).","journal-title":"Methods Mol. Biol."},{"key":"BFnrrheum2016147_CR120","first-page":"844","volume":"123","author":"J Idoyaga","year":"2013","unstructured":"Idoyaga, J.  et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J. Clin. Invest. 123, 844\u2013854 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrrheum2016147_CR121","doi-asserted-by":"publisher","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","volume":"7","author":"H Benham","year":"2015","unstructured":"Benham, H.  et al. Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients. Sci. Transl. Med. 7, 290ra87 (2015).","journal-title":"Sci. Transl. Med."},{"key":"BFnrrheum2016147_CR122","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/cei.12038","volume":"172","author":"CMU Hilkens","year":"2013","unstructured":"Hilkens, C. M. U. & Isaacs, J. D. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin. Exp. Immunol. 172, 148\u2013157 (2013).","journal-title":"Clin. Exp. Immunol."},{"key":"BFnrrheum2016147_CR123","unstructured":"US National Library of Medicine. Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis (AutoDECRA) ClinicalTrials.gov [online], \n                    https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01352858\n                    \n                   (2013)."},{"key":"BFnrrheum2016147_CR124","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1084\/jem.20132620","volume":"211","author":"SL Rowland","year":"2014","unstructured":"Rowland, S. L.  et al. Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model. J. Exp. Med. 211, 1977\u20131991 (2014).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR125","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1084\/jem.20132522","volume":"211","author":"V Sisirak","year":"2014","unstructured":"Sisirak, V.  et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 211, 1969\u20131976 (2014).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR126","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/ard.2010.144485","volume":"70","author":"JT Merrill","year":"2011","unstructured":"Merrill, J. T.  et al. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon \u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann. Rheum. Dis. 70, 1905\u20131913 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrrheum2016147_CR127","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/art.37824","volume":"65","author":"M Petri","year":"2013","unstructured":"Petri, M.  et al. Sifalimumab, a human anti-interferon-\u03b1 monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study. Arthritis Rheum. 65, 1011\u20131021 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR128","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1002\/art.34632","volume":"64","author":"JM McBride","year":"2012","unstructured":"McBride, J. M.  et al. Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study. Arthritis Rheum. 64, 3666\u20133676 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR129","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/art.37785","volume":"65","author":"BR Lauwerys","year":"2013","unstructured":"Lauwerys, B. R.  et al. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon \u03b1-kinoid. Arthritis Rheum. 65, 447\u2013456 (2013).","journal-title":"Arthritis Rheum."},{"key":"BFnrrheum2016147_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-417028-5.00001-6","volume":"120","author":"M Haniffa","year":"2013","unstructured":"Haniffa, M., Collin, M. & Ginhoux, F. Ontogeny and functional specialization of dendritic cells in human and mouse. Adv. Immunol. 120, 1\u201349 (2013).","journal-title":"Adv. Immunol."},{"key":"BFnrrheum2016147_CR131","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.it.2013.06.001","volume":"34","author":"E Segura","year":"2013","unstructured":"Segura, E. & Amigorena, S. Inflammatory dendritic cells in mice and humans. Trends Immunol. 34, 440\u2013445 (2013).","journal-title":"Trends Immunol."},{"key":"BFnrrheum2016147_CR132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1084\/jem.20141442","volume":"212","author":"J Lee","year":"2015","unstructured":"Lee, J.  et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J. Exp. Med. 212, 385\u2013399 (2015).","journal-title":"J. Exp. Med."},{"key":"BFnrrheum2016147_CR133","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1084\/jem.20141441","volume":"212","author":"G Breton","year":"2015","unstructured":"Breton, G.  et al. Circulating precursors of human CD1c+ and CD141+ dendritic cells. J. Exp. Med. 212, 401\u2013413 (2015).","journal-title":"J. Exp. Med."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.147","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrrheum.2016.147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:38:48Z","timestamp":1684456728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrrheum.2016.147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,22]]},"references-count":133,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFnrrheum2016147"],"URL":"https:\/\/doi.org\/10.1038\/nrrheum.2016.147","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,22]]},"assertion":[{"value":"22 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}